Effects of maternal separation and methamphetamine exposure on protein expression in the nucleus accumbens shell and core

Metabolic Brain Disease

Volumn 27, Issue 3, 2012, Pages 363-375

  Dimatelis, J J ^a   Russell, V A ^a   Stein, D J ^a   Daniels, W M ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Drugs of abuse; Early life stress; Proteomics; Ventral striatum

Indexed keywords

CYTOSKELETON PROTEIN; METHAMPHETAMINE; NEUROTROPHIC FACTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EARLY LIFE STRESS; ENERGY METABOLISM; FUNCTIONAL PROTEOMICS; MALE; MATERNAL DEPRIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OXIDATION REDUCTION REACTION; PERINATAL DRUG EXPOSURE; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANIMALS, NEWBORN; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; MALE; MATERNAL DEPRIVATION; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

ANIMALIA; RATTUS;

EID: 84864423743     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9295-9     Document Type: Article

References (104)

1. Aderem A (1992) The MARCKS brothers: a family of protein kinase C substrates. Cell 71:713-716. doi:10.1016/0092-8674(92)90546-0
2. Aitken A (1995) 14-3-3 proteins on the MAP. Trends Biochem Sci 20:95-97. doi:10.1016/S0968-0004(00)88971-9
3. Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:162-172. doi:10.1016/j.semcancer.2006.03.005
4. Ajjappala BS, Kim YS, Kim MS, Lee MY, Lee KY, Ki HY, Cha DH, Baek KH (2009) 14-3-3γ is stimulated by IL-3 and promotes cell proliferation. J Immunology 182:1050-1060
5. Arbuzova A, Murray D, McLaughlin S (1998) MARCKS, membranes, and calmodulin: kinetics of their interaction. Biochem Biophys Acta 1376:369-379. doi:10.1016/S0304-4157(98)00011-2
6. Arbuzova A, Schmitz AA, Vergères G (2002) Cross-talk unfolded: MARCKS proteins. Biochem J 362:1-12
7. Bassareo V, Musio P, Di Chiara G (2011) Reciprocal responsiveness of nucleus accumbens shell and core dopamine to food- and drug-conditioned stimuli. Psychopharmacology 214:687-697. doi:10.1007/s00213-010-2072-8
8. Blackshear PJ (1993) The MARCKS family of cellular protein kinase C substrates. J Biol Chem 268:1501-1504
9. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49:226-231. doi:10.1002/syn.10226
10. Border BG, Lin SC, Griffin WS, Pardue S, Morrison-Bogorad M (1993) Alterations in actin-binding beta-thymosin expression accompany neuronal differentiation and migration in rat cerebellum. J Neurochem 61:2104-2114
11. Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A (2004) Influence of early postnatal rearing conditions on mesocortico-limbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur J Neurosci 19:1863-1874. doi:10.1111/j.1460-9568.2004.03286.x
12. Brenz Verca MS, Bahi A, Boyer F, Wagner GC, Dreyer JL (2003) Distribution of alpha- and gamma-synucleus in the adult rat brain and their modification by high-dose cocaine treatment. Eur J Neurosci 18:1923-1938. doi:10.1046/j.1460- 9568.2003.02913.x
13. Bridges D, Moorhead GB (2005) 14-3-3 proteins: a number of functions for a numbered protein. Sci STKE 296:re10. doi:10.1126/stke.2962005re10
14. Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC Jr, Nairn AC, Greengard P (2000) Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia. Neuro-pharmacol 39:1637-1644. doi:10.1016/S0028-3908(99) 00230-0
15. Carboni E, Imperato A, Perezzani L, Di Chara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653-661
16. Carpintero P, Anadon R, az-Regueira S, Gomez-Marquez J (1999) Expression of thymosin beta4 messenger RNA in normal and kainite-treated rat forebrain. Neuroscience 90:1433-1444. doi:10.1016/S0306-4522(98)00494-1
17. Chan P, Monte DA, Luo JJ, DeLanney LE, Irwin I, Langston JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62:2484-2487. doi:10.1046/ j.1471-4159.1994.62062484.x
18. Chen S, Fariss RN, Kutty RK, Nelson R, Wiggert B (2006) Fenretinide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells is associated with the differential expression of Hsp, 70, 14-3-3, pax-6, tubulin β-III, NSE, and bag-1 proteins. Mol Vis 12:1355-1363
19. Chung KK, Dawson VL, Dawson TM (2001) The role of the ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurol Sci 24:S7-S14. doi:10.1016/S0166-2236(00)01998-6
20. Clarke PR, Siddhanti SR, Cohen P, Blackshear PJ (1993) Okadaic acid-sensitive protein phosphatases dephosphorylate MARCKS, a major protein kinase C substrate. FEBS Lett 336:37-42. doi:10.1016/0014-5793(93)81604-X
21. Conway KA, Rocket JC, Bieganski RM, Lansbury J (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 276:2045-2047
22. Daniels WM, Marais L, Stein DJ, Russell VA (2011) iTRAQ analysis indicates that exercise normalizes altered expression of proteins in the ventral hippocampus of rats subjected to maternal separation. Exp Physiol, In Press. doi: 10.1113/expphysiol.2011.061176
23. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81-96. doi:10.1016/S0006-3223(00)01038-6
24. Faure JJ, Hattingh SM, Stein DJ, Daniels WM (2009) Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment. Metab Brain Dis 24:685-700. doi:10.1007/s11011-009- 9167-0
25. Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, Capobianco L, Battaglia G, De Blasi A, Nicoletti F, Paparelli A (2004a) Meth-amphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J Neurochem 88:114-123. doi:10.1046/ j.1471-4159.2003.02137.x
26. Fornai F, Lenzi P, Gesi M, Ferrucci M, Lazzeri G, Capobianco L, De Blasi A, Battaglia G, Nicoletti F, Ruggieri S, Paparelli A (2004b) Similarities between methamphetamine toxicity and proteasome inhibition. Ann NY Acad Sci 1025:162-170. doi:10.1196/ annals.1316.021
27. Frey D, Laux T, Xu L, Schneider C, Caroni P (2000) Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol 149:1443-1454. doi:10.1083/jcb.149.7.1443
28. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J (2000) Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:639-648
29. Frodl T, Reinhold E, Koutsouleris N, Reiser M, Meisenzahl EM (2010) Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression. J Psychiatr Res 44:799-807. doi:10.1016/j. jpsychires.2010.01.006
30. Fujigasaki H, Song SY, Kobayashi T, Yamakuni T (1996) Murine central neurons express a novel member of the cdc10/SW16 motif-containing protein superfamily. Mol Brain Res 40:203213. doi:10.1016/0169-328X(96)00005-8
31. Goldschmidt-Clermont PJ, Furman MI, Wachsstock D, Safer D, Nachmias VT, Pollard TD (1992) The control of actin nucleotide exchange by thymosin beta4 and profilin. A potential regulatory mechanism for actin polymerization in cells. Mol Biol Cell 3:1015-1024
32. Hamidovic A, Childs E, Conrad M, King A, de Wit H (2010) Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend 109:175-180. doi:10.1016/ j.drugalcdep.2009.12.029
33. Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E (2001) β-synuclein inhibits α-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32:213-223. doi:10.1016/ S0896-6273(01)00462-7
34. Hashimoto M, Bar-on P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E (2004) β-synuclein regulates Akt activity in neuronal cells. J Biol Chem 279:23622-23629. doi:10.1074/jbc.M313784200
35. Hattori T, Ohsawa K, Mizuno Y, Kato K, Kohsaka S (1994) Synthetic peptide corresponding to 30 aminoacids of the C terminal of neuron specific enolase promotes survival of neocortical neurons in culture. Biochem Biophys Res Commun 202:25-30. doi:10.1006/bbrc.1994.1888
36. Huang YH, Tsai SJ, Su TW, Sim CB (1999) Effects of repeated highdose methamphetamine on local cerebral glucose utilization in rats. Neuropsychopharmacol 21:427-434
37. Huff T, Muller CS, Otto AM, Netzker R, Hannappel E (2001) Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33:205-220. doi:10.1016/S1357-2725(00)00087-X
38. Iino S, Maekawa S (1999) Immunohistochemical demonstration of a neuronal calmodulin-binding protein, NAP-22, in the rat spinal cord. Brain Res 834:66-73. doi:10.1016/S0006-8993(99)01543-7
39. Imperato A, Di Chara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219-228
40. Imperato A, Mulas A, Di Chara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
41. Ivkovic S, Blau S, Polanskaya O, Ehrlich ME (1996) ARPP-21: murine gene structure and promoter identification of a neuronal phosphoprotein enriched in the limbic striatum. Brain Res 709:10-16. doi:10.1016/0006-8993(95)01248-6
42. Iwazaki T, McGregor IS, Matsumoto I (2006) Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res 1097:19-25. doi:10.1016/j.brainres.2006.04.052
43. Iwazaki T, McGregor IS, Matsumoto I (2007) Protein expression profile in the striatum of rats with methamphetamine-induced behavioural sensitization. Proteomics 7:1131-1139. doi:10.1002/ pmic.200600595
44. Iwazaki T, McGregor IS, Matsumoto I (2008) Protein expression profile in the amygdala of rats with methamphetamine-induced behavioural sensitization. Neurosci Lett 435:113-119. doi: 10.1016/j.neulet.2008.02.025
45. Jin J, Smith FD, Starck C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD, Pawson T (2004) Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14:1436-1450. doi:10.1016/j.cub.2004.07.051
46. Kang F, Purich DL, Southwick FS (1999) Profilin promotes barbed-end actin filament assembly without lowering the critical concentration. J Biol Chem 274:36963-36972. doi:10.1074/ jbc.274.52.36963
47. Kikusui T, Faccidomo S, Miczek KA (2005) Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice. Psychopharmacology 178:202-210. doi:10.1007/s00213-004-1989-1
48. Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS, Jeong DU, Renshaw PF (2005) Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacol 30:1383-1391. doi:10.1038/sj.npp.1300699
49. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H, Hosokawa M (2002) Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160:869-882. doi:10.1016/S0002-9440(10)64910-3
50. Kobeissy FH, Warren MW, Ottens AK, Sadasivan S, Zhang Z, Gold MS, Wang KKW (2008) Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. J Proteome Res 7:1971-1983. doi:10.1021/pr800029h
51. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476. doi:10.1016/S0896-6273(00)80557-7
52. Korshunova I, Caroni P, Kolkova K, Berezin V, Bock E, Walmod PS (2008) Characterization of BASP1-mediated neurite outgrowth. J Neurosci Res 86:2201-2213. doi:10.1002/jnr.21678
53. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM (2000) Long-term behavioural and neuroendorine adaptations to adverse early experience. In: Mayer EA, Saper CB (eds) Progress in brain research: the biological basis for mind body interactions. Elsevier, Amsterdam, pp 81-103
54. Laviola G, Adriani W, Terranova ML, Gerra G (1999) Psychobiolog-ical risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci Biobehav Rev 23:9931010. doi:10.1016/S0149-7634(99)00032-9
55. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik NB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865
56. Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A (2002) Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacol 27:1027-1035
57. Li X, Wang H, Qiu P, Luo H (2008) Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain. Neurochem Int 52:256-264. doi:10.1016/j.neuint.2007.06.014
58. Liao PC, Kuo YM, Hsu HC, Cherng CG, Lung Y (2005) Local proteins associated with methamphetamine-induced nigrostriatal Ö dopaminergic neurotoxicity. J Neurochem 95:160-168. doi:10.1111/j.1471-4159.2005.03346.x
59. Lotharius J, Brundin P (2002) Pathogenesis of Parkinson's disease: dopamine vesicles and α-synuclein. Nat Rev Neurosci 3:932-942
60. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153-160
61. Machida Y, Chiba T, Takayanagi A, Tanaka Y, Asanuma M, Ogawa N, Koyama A, Ito S, Jansen PH, Tanaka K, Hattori N (2005) Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells. Biochem Biophys Res Commun 24:233-240. doi:10.1016/j.bbrc.2005.04.124
62. Marais L, Hattingh SM, Stein DJ, Daniels WMU (2009) A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment. Metab Brain Dis 24:569586. doi:10.1007/s11011-009-9156-3
63. Matthews K, Robbins TW (2003) Early experience as a determinant of adult behavioural responses to reward: the effects of repeated maternal separation in the rat. Neurosci Biobehav Rev 27:4555. doi:10.1016/S0149-7634(03)00008-3
64. McCann UD, Ricaurte GA (2004) Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 27:821-826. doi:10.1016/j. neubiorev.2003.11.003
65. Meaney MJ, Brake W, Gratton A (2002) Environmental regulation of the development of mesolimbic dopamine systems: a neurobio-logical mechanism for vulnerability to drug abuse? Psychoneuroendocrinology 27:127-138. doi:10.1016/S0306-4530(01)00040-3
66. Misasi R, Sorice M, Di Marzio L, Campana WM, Molinari S, Cifone MG, Pavan A, Pontieri GM, O'Brien JS (2001) Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase. FASEB J 15:467-474. doi:10.1096/fj.00-0217com
67. Missale A, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225
68. Molitoris BA (1997) Putting the actin cytoskeleton into perspective: pathophysiology of ischemic alterations. Am J Physiol 272:430433
69. Mosevitsky MI, Novitskaya VA, Plekhanov AY, Skladchikova GY (1994) Neuronal protein GAP-43 is a member of novel group of brain acid-soluble proteins (BASPs). Neurosci Res 19:223-228
70. Mzhavia N, Berman Y, Che F, Fricker LD, Devi LA (2001) ProSAAS processing in mouse brain and pituitary. J Biol Chem 276:62076213. doi:10.1074/jbc. M009067200 Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD (2002) Processing of proSAAS in neuroendocrine cell lines. Biochem J 361:67-76
71. Mzhavia N, Qian Y, Feng Y, Che FY, Devi LA, Fricker LD (2002) Processing of proSAAS in neuroendocrine cell lines. Biochem J 361:67-76
72. Ohmori S, Sakai N, Shirai Y, Yamamoto H, Miyamoto E, Shimizu N, Saito N (2000) Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoylated alanine-rich C-kinase substrate. J Biol Chem 275:26449-26457. doi:10.1074/jbc.M003588200
73. Otero A, Bustelo XR, Pichel JG, Freire M, Gomez-Marquez J (1993) Transcript levels of thymosin beta 4, an actin-sequestering peptide, in cell proliferation. Biochem Biophys Acta 1176:59-63
74. Ouimet CC, Hemmings HC Jr, Greengard P (1989) ARP-21. II. Im-munocytochemical localization in rat brain. J Neuroscience 9:865-875
75. Pantaloni D, Cartier MF (1993) How profilin promotes actin filament assembly in the presence of thymosin beta4. Cell 75:1007-1014. doi:10.1016/0092-8674(93)90544-Z
76. Paxinos G, Watson C (1986) The rat brain on stereotaxic co-ordinates, 2nd edn. Academic, San Diego Popoli P, Pepponi R, Martire A, Armida M, Pezzola A, Galluzzo M, Domenici MR, Potenza RL, Tebano MT, Mollinari C, Merlo D, Garaci E (2007) Neuroprotective effects of thymosin beta4 in experimental models of excitotoxicity. Ann NY Acad Sci 1112:219-224. doi:10.1196/annals.1415.033
77. Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD (2000) The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem 275:23596-23601. doi:10.1074/jbc.M001583200
78. Safer D, Elzinga M, Nachmias VT (1991) Thymosin beta4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 266:4029-4032
79. Schmidt HD, Anderson SM, Pierce RC (2006) Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Eur J Neurosci 23:219-228. doi: 10.1111/ j.1460-9568.2005.04524.x
80. Schmidt MV, Liebl C, Sterlemann V, Ganea K, Hartmann J, Harbich D, Alam S, Müller MB (2008) Neuropeptide Y mediates the initial hypothalamic-pituitary-adrenal response to maternal separation in the neonatal mouse. J Endocrinol 197:421-427. doi:10.1677/JOE-07-0634
81. Seki K, Chen HC, Huang KP (1995) Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A. Arch Biochem Biophys 316:673-679. doi:10.1006/abbi.1995. 1090
82. Shimosato K, Ohkuma S (2000) Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine. Pharmacol Biochem Behav 66:285-292. doi:10.1016/s0091-3057(00)00185-4
83. Sinha R, Catapano D, O'Malley S (1999) Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology 142:343-351. doi:10.1007/s002130050898
84. Söderpalm A, Nikolayev L, de Wit H (2003) Effects of stress on responses to methamphetamine in humans. Psychopharmacology 170:188-199. doi: 10.1007/s00213-003-1536-5
85. Sorice M, Molinari S, Di Marzio L, Mattei V, Tasciotti V, Ciarlo L, Hiraiwa M, Garofalo T, Misasi R (2008) Neurotrophic signaling pathway triggered by prosaposin in PC 12 cells occurs through lipid rafts. FEBS J 275:4903-4912. doi:10.1111/j.1742-4658.2008.06630.x
86. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463. doi: 10.1016/S0149-7634(00) 00014-2
87. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
88. Stoof J, Kebabian J (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368
89. Sulzer D (2001) Alpha-synculein and cytosolic dopamine: stabilizing a bad situation. Nat Med 7:1280-1282. doi:10.1038/nm1201-1280
90. Taoka M, Yamakuni T, Song SY, Yamakawa Y, Seta K, Okuyama T, Isobe T (1992) A rat cerebellar protein containing the cdc10/ SW16 motif. Eur J Biochem 207:615-620. doi:10.1111/j.1432-1033.1992.tb17088.x
91. Taoka M, Isobes T, Okuyama T, Watanabe M, Kondo H, Yamakawa Y, Ozawa F, Hishinuma F, Kubota M, Minegishi A, Song SY, Yamakuni T (1994) Murine cerebellar neurons express a novel gene encoding a protein related to cell cycle control and cell fate determination proteins. J Biol Chem 269:9946-9951
92. Thelen M, Rosen A, Nairn AC, Aderem A (1991) Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature 351:320-322. doi:10.1038/351320a0
93. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C (2003))Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 75:1895-1904
94. Vale RD, Banker G, Hall ZW (1992) The neuronal cytoskeleton. In: Hall ZW, Sunderland MA (eds) An introduction to molecular neurobiology. Sinuaer Associates, USA, pp 247-280
95. van Harmelen A-L, van Tol M-J, van der Wee NJA, Veltman DJ, Aleman A, Spinhoven P, van Buchem MA, Zitman FG, Penninx BWJH, Elzinga BM (2010) Reduced medial prefrontal cortex volume in adults reporting childhood emotional maltreatment. Biol Psychiatry 68:832-838. doi:10.1016/j.biolpsych.2010.06.011
96. Vartiainen N, Pyykonen I, Hokfelt T, Koistinaho J (1996) Induction of thymosin beta(4) mRNA following focal brain ischemia. Neuroreport 7:1613-1616
97. Walaas SI, Nairn AC, Greengard P (1983) Regional distribution of calcium- and cyclic AMP-regulated protein phosphorylation systems in mammalian brain II. Soluble system. J Neurosci 3:302311
98. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR (2001) Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann NY Acad Sci 937:1-26. doi:10.1111/j.1749-6632.2001.tb03556.x
99. Wiederkehr A, Staple J, Caroni P (1997) The motility-associated proteins GAP-43, MARCKS, and CAP-23 share unique targeting and surface activity-inducing properties. Exp Cell Res 236:103116. doi: 10.1006/excr.1997.3709
100. Wu YL, Yoshida M, Emoto H, Tanaka M (1999) Psychological stress selectively increases extracellular dopamine in the 'shell', but not in the 'core' of the rat nucleus accumbens: a novel dual-needle probe simultaneous microdialysis study. Neurosci Lett 275:6972. doi: 10.1016/S0304-3940(99)00747-8
101. Yamakuni T, Yamamoto T, Hoshino M, Song SY, Yamamoto H, Kunikata-Sumitomo M, Minegishi A, Kubota M, Ito M, Konishi S (1998) A novel protein containing cdc10/SW16 motifs regulates expression of mRNA endocing catecholamine biosynthesizing enzymes. J Biol Chem 273:27051-27054. doi:10.1074/ jbc.273.42.27051
102. Yang MH, Kim S, Jung MS, Shim JH, Ryu NK, Yook YJ, Jang CG, Bahk YY, Kim KW, Park JH (2008) Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict Biol 13:287-294. doi:10.1111/j.1369-1600.2007.00090.x
103. Zhou Y, Schlussman SD, Ho A, Spangler R, Fienberg AA, Greengard P, Kreek MJ (1999) Effects of chronic "binge" cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. Neuroendocrinology 70:196-199. doi:10.1159/000054476
104. Zhuang X, Belluscio L, Hen R (2000) Golfalpha mediates dopamine D1 receptor signaling. J Neurosci 20:1-5